[go: up one dir, main page]

EA200000934A1 - Среда и способ осуществления роста и размножения вирусов - Google Patents

Среда и способ осуществления роста и размножения вирусов

Info

Publication number
EA200000934A1
EA200000934A1 EA200000934A EA200000934A EA200000934A1 EA 200000934 A1 EA200000934 A1 EA 200000934A1 EA 200000934 A EA200000934 A EA 200000934A EA 200000934 A EA200000934 A EA 200000934A EA 200000934 A1 EA200000934 A1 EA 200000934A1
Authority
EA
Eurasian Patent Office
Prior art keywords
viruses
reproduction
growth
implementing
environment
Prior art date
Application number
EA200000934A
Other languages
English (en)
Inventor
Пьер Хайминдингер
Original Assignee
Авентис Пастеэр
Мериаль С.А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Авентис Пастеэр, Мериаль С.А.С. filed Critical Авентис Пастеэр
Publication of EA200000934A1 publication Critical patent/EA200000934A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0043—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32651—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к среде для роста и размножения вирусов на культивируемых клетках, отличающейся тем, что она не содержит белков человека или животных и тем, что она содержит белки или гликопротеины, экстрагированные из картофеля или огурцов, обладающие митогенным потенциалом и молекулярной массой от 1000 до 200000 Д, и/или гидролизаты растительных экстрактов.Отчет о международном поиске был опубликован 1999.11.04.
EA200000934A 1998-03-13 1999-03-15 Среда и способ осуществления роста и размножения вирусов EA200000934A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9803333A FR2775983B1 (fr) 1998-03-13 1998-03-13 Milieu et procede de propagation et de multiplication virales
PCT/FR1999/000578 WO1999047648A2 (fr) 1998-03-13 1999-03-15 Milieu et procede de propagation et de multiplication virales

Publications (1)

Publication Number Publication Date
EA200000934A1 true EA200000934A1 (ru) 2001-02-26

Family

ID=9524203

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000934A EA200000934A1 (ru) 1998-03-13 1999-03-15 Среда и способ осуществления роста и размножения вирусов

Country Status (16)

Country Link
EP (1) EP1062324A2 (ru)
JP (1) JP2002506636A (ru)
KR (1) KR20010072556A (ru)
CN (1) CN1301297A (ru)
AU (1) AU752577B2 (ru)
BR (1) BR9908744A (ru)
CA (1) CA2322619A1 (ru)
EA (1) EA200000934A1 (ru)
FR (1) FR2775983B1 (ru)
HU (1) HUP0101081A3 (ru)
IL (1) IL138250A0 (ru)
NZ (1) NZ506872A (ru)
PL (1) PL343557A1 (ru)
SK (1) SK12882000A3 (ru)
TR (1) TR200002641T2 (ru)
WO (1) WO1999047648A2 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000083657A (ja) * 1998-07-13 2000-03-28 Chemo Sero Therapeut Res Inst 日本脳炎ウイルスワクチン
AT409379B (de) * 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
CA2441688C (en) * 2001-03-27 2014-01-21 Vertex Pharmaceuticals Incorporated Compositions and methods useful for hcv infection
EP2287288B1 (en) * 2002-07-09 2012-11-07 Baxter International Inc. Animal protein free media for cultivation of cells
GB0304799D0 (en) 2003-03-03 2003-04-09 Glaxosmithkline Biolog Sa Novel method
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
ES2629304T3 (es) 2006-01-04 2017-08-08 Baxalta Incorporated Medio de cultivo celular sin oligopéptidos
JP5458536B2 (ja) * 2008-09-17 2014-04-02 不二製油株式会社 乳酸の製造方法及び乳酸発酵用添加剤
CN107043739A (zh) * 2017-04-24 2017-08-15 浙江美保龙生物技术有限公司 一种Vero细胞培养液添加剂及其制备方法、使用方法
CN107129963A (zh) * 2017-04-24 2017-09-05 浙江美保龙生物技术有限公司 一种df‑1细胞培养液添加剂及其制备方法、使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498537A (en) * 1994-03-09 1996-03-12 Cellco, Inc. Serum-free production of packaged viral vector
FR2732347A1 (fr) * 1995-03-30 1996-10-04 Bio Media Extrait vegetal, son procede de preparation et ses applications en medecine humaine ou veterinaire
ES2191296T3 (es) * 1997-04-16 2003-09-01 Feva N V Extractos vegetales, metodo para su preparacion y sus aplicaciones en medicina humana y veterinaria.

Also Published As

Publication number Publication date
PL343557A1 (en) 2001-08-27
FR2775983B1 (fr) 2000-11-10
CN1301297A (zh) 2001-06-27
CA2322619A1 (en) 1999-09-23
AU2735299A (en) 1999-10-11
FR2775983A1 (fr) 1999-09-17
IL138250A0 (en) 2001-10-31
AU752577B2 (en) 2002-09-26
HUP0101081A2 (hu) 2001-07-30
EP1062324A2 (fr) 2000-12-27
JP2002506636A (ja) 2002-03-05
HUP0101081A3 (en) 2003-04-28
SK12882000A3 (sk) 2001-05-10
NZ506872A (en) 2002-03-01
WO1999047648A3 (fr) 1999-11-04
TR200002641T2 (tr) 2000-11-21
WO1999047648A2 (fr) 1999-09-23
BR9908744A (pt) 2000-12-26
KR20010072556A (ko) 2001-07-31

Similar Documents

Publication Publication Date Title
ATE193550T1 (de) Rekonstruiertes knorpelgewebe
EA199900381A1 (ru) Арил(тио)эфиры галогенпиримидина в качестве пестицидов
NO20003961L (no) Osteoimplantat og fremgangsmÕte for fremstilling derav
CO4700552A1 (es) Lineas de celulas inmortalizadas para el crecimiento de virus
EA200000934A1 (ru) Среда и способ осуществления роста и размножения вирусов
TW367365B (en) An improved method for obtaining plant somatic embryos about the somatic embryo suspension cultures and pro-embryogenic mass suspension cultures
RU2003113779A (ru) Добавка к питательной среде для культуры животной клетки
EA200100362A1 (ru) Способы лечения множественной миеломы и индуцированной миеломой резорбции костей с помощью антагонистов интегрина
IT8667623A1 (it) Composizione e procedimento per la conservazione di vegetali, particolarmente fiori e piante.
EA199800840A1 (ru) Средство и способ получения воды для аквариумов и садовых прудов
TR200002101T2 (tr) Dondurulmuş gıda ürünü.
DE59103696D1 (de) Biomasse zur produktion von virus/virusantigen.
ATE142431T1 (de) Tierfutter zur leistungssteigerung
GB2399819A (en) Method of transducing es cells
DE69009137D1 (de) Behandlungsverfahren zur Konservierung von frischen pflanzlichen Lebensmitteln.
DK1012186T3 (da) Keratinocyt-vækstfaktorer og anvendelser deraf
FR2513122B1 (ru)
NO914764D0 (no) Supplement for kresne organismer
DE59102581D1 (de) Verfahren zur gewinnung von naturtrüben frucht- und gemüsesäften.
NL1005843A1 (nl) Bewerkingsinrichting voor halmgewas.
RU96123779A (ru) Способ получения иммуностимулятора
DE58903200D1 (de) Pflanzenwuchshemmendes mittel.
BG37372A3 (bg) Средство за регулиране растежа на растения
PT818960E (pt) Desoxigenacao dum alimento utilizando lacase
DE60007991D1 (de) Verwendung des proteins uk 114 zur verhinderung der abstossung eines transplantierten organs